VIDEO: Hiren Shah, MD, Talks VTE Updates and MAGELLAN Trial
By DocWire News Editors - Last Updated: August 24, 2023In this first part of a two-part interview, Dr. Hiren Shah, an assistant professor of medicine at the Feinberg School of Medicine at Northwestern University, talks to DocWire News about recent developments in venous thromboembolism (VTE) treatment and therapy, as well as a quick discussion of the results of the MAGELLAN study.
Advertisement
Click here for more on the MAGELLAN study.
Advertisement
Related Posts
Investigation of a HUNT Study cohort found elevated plasma MBL levels to be associated with increased risk for future VTE.
A cohort study of extended-phase anticoagulation following acute management was performed in the phase III EINSTEIN Jr trial.
The Clinical Practice Guidance document issued by the EHA, ISTH, EAHAD, and ESO addresses both hemophilia A and B.
The reduced-dose oral regimen also had lower incidence of clinically relevant bleeding complications and mortality rate.
In findings arterial thrombosis carried worse overall survival than venous thrombosis in this patient population.
630 Madison Ave.
Manalapan, NJ 07726
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.